BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1170923)

  • 1. An abnormality of oestrogen feedback in amenorrhoea-galactorrhoea.
    Glass MR; Shaw RW; Butt WR; Edwards RL; London DR
    Br Med J; 1975 Aug; 3(5978):274-5. PubMed ID: 1170923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactorrhoea-amenorrhoea and hyperprolactinaemia: pathophysiological aspects and diagnostic tests.
    Tolis G
    Clin Endocrinol (Oxf); 1977; 6 Suppl():81S-89S. PubMed ID: 568528
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypothalamo-hypophyseal-ovarian interrelationships in the galactorrhea-amenorrhea syndrome].
    Maleeva A; Volkov I
    Akush Ginekol (Mosk); 1980 Jun; (6):24-6. PubMed ID: 6773433
    [No Abstract]   [Full Text] [Related]  

  • 4. Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea.
    Aono T; Miyake A; Yasuda TS; Koike K; Kurachi K
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):591-600. PubMed ID: 227202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sequential pituitary stimulation test in normal subjects and in patients with amenorrhea-galactorrhea with pituitary tumors.
    Kletzky OA; Davajan V; Mishell DR; Nicoloff JT; Mims R; March CM; Nakamura RM
    J Clin Endocrinol Metab; 1977 Oct; 45(4):631-40. PubMed ID: 410820
    [No Abstract]   [Full Text] [Related]  

  • 6. [Amenorrhea-galactorrhea syndrome: clinical characteristics, prolactin secretion and estrogenic activity].
    Teter J; Paszko Z; Polańska A; Radowicki S; Kwiatkowska E
    Ginekol Pol; 1983; 54(1):23-9. PubMed ID: 6407903
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dynamic evaluation of hypothalamic-pituitary function in women with the syndrome of galactorrhea (author's transl)].
    Kawagoe S; Saito H; Ogawa T; Hiroi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):61-9. PubMed ID: 6801158
    [No Abstract]   [Full Text] [Related]  

  • 8. Pituitary function testing in amenorrhea-galactorrhea-hyperprolactinemia.
    Simpson CW; Plunkett ER
    Fertil Steril; 1979 Nov; 32(5):510-7. PubMed ID: 115722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic-pituitary evaluation in patients with galactorrhea-amenorrhea and hyperprolactinemia.
    Badawy SZ; Nusbaum ML; Omar M
    Obstet Gynecol; 1980 Jan; 55(1):1-7. PubMed ID: 6243406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The control of gonadotrophin release in women with hyperprolactinaemic amenorrhoea: effect of oestrogen and progesterone on the LH and FSH response to LHRH.
    Glass MR; Shaw RW; Williams JW; Butt WR; Logan-Edwards R; London DR
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):521-30. PubMed ID: 791539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamus-pituitary function in amenorrhea-galactorrhea syndrome.
    Delitala G; Masala A; Alagna S; Devilla L
    Panminerva Med; 1978; 20(2):89-96. PubMed ID: 212704
    [No Abstract]   [Full Text] [Related]  

  • 12. Gonadotropic responsiveness to clomiphene, LRH, estradiol, and bromocriptine in galactorrheic women.
    Forsbach G; Soria J; Canales ES; Guzman V; Cabezas A; Zárate A
    Obstet Gynecol; 1977 Aug; 50(2):139-44. PubMed ID: 327363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of pituitary function in patients with serum prolactin levels greater than 100 ng/ml.
    Blackwell RE; Boots LR; Goldenberg RL; Younger JB
    Fertil Steril; 1979 Aug; 32(2):177-82. PubMed ID: 572785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical study on the characteristics of galactorrhea-amenorrhea (especially of drug-induced galactorrhea-amenorrhea].
    Onda H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1851-60. PubMed ID: 6438254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary and ovarian response patterns to stimulation in the postpartum and in galactorrhea-amenorrhea. The role of prolactin.
    del Pozo E; Varga L; Schulz KD; Künzig HJ; Marbach P; del Campo GL; Eppenberger U
    Obstet Gynecol; 1975 Nov; 46(5):539-43. PubMed ID: 1105275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and endocrine features of hyperprolactinaemic amenorrhoea.
    Jacobs HS; Franks S; Murray MA; Hull MG; Steele SJ; Nabarro JD
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):439-54. PubMed ID: 825329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional evaluation of pituitary reserve in patients with the amenorrhea-galactorrhea syndrome utilizing luteinizing hormone-releasing hormone (LH-RH), L-dopa and chlorpromazine.
    Zárate A; Jacobs LS; Canales ES; Schally AV; De la Cruz A; Soria J; Daughaday WH
    J Clin Endocrinol Metab; 1973 Dec; 37(6):855-9. PubMed ID: 4584924
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antigonadotropic actions of prolactin. Study of 10 cases of women with hyperprolactinemia].
    Schaison G; Mowszowicz I; Cesselin E; Lagoguey M
    Nouv Presse Med; 1977 Feb; 6(6):425-8. PubMed ID: 320558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in pituitary gonadotropins during the amenorrhoea-galactorrhoea syndrome due to sulpiride.
    Buvat J; Thomas K; Racadot A; Blacker C; Buvat-Herbaut M; Ferin F; Linquette M
    Clin Endocrinol (Oxf); 1978 Dec; 9(6):499-504. PubMed ID: 371860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dosage of prolactin in normal and pathological subjects (author's transl)].
    Franchimont P; Dourcy C; Legros JJ; Reuter A; Vrindts-Gevaert Y; van Cauwenberge JR; Remacle P; Gaspard U; Colin C
    Ann Endocrinol (Paris); 1976; 37(3):127-56. PubMed ID: 828474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.